Answers are grounded in this paper and cite their sources.
Osteosarcoma (OS) transcriptomic characterization is constrained by disease rarity, mandatory bone decalcification, and preservation-induced RNA damage. We assessed the impact of tissue preservation on bulk transcriptomic profiling by comparing RNA sequencing data from fresh-frozen (FF) and formalin-fixed paraffin-embedded (FFPE) OS specimens across in-house and public datasets. Sequencing performance and biological fidelity were evaluated through quality-control metrics, dimensionality reduction, pathway enrichment, tissue-specific signatures, and immune cell deconvolution. FF samples retained high alignment rates, tissue identity, and coherent OS-specific transcriptional programs. In contrast, FFPE datasets showed prominent preservation-associated effects, reduced biological specificity, and limited concordance with FF profiles. Immune deconvolution yielded robust results in FF datasets, revealing a macrophage-dominated immunosuppressive microenvironment. Although retrospective FFPE cohorts remain valuable in rare tumors, the limited proportion of biologically informative specimens supports coordinated prospective multicenter collection of FF samples for robust transcriptomic studies.
No takes yet. Share an insight, caveat, or question.
Betti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: